Neuroone Medical Technologies

Quarterly Financials

Values in thousands 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue
$1,696
$1,386
$3,274
$272
Gross Profit
914
771
1,926
141
EBITDA
-1,424
-2,204
2,175
-3,057
EBIT
-1,491
-2,270
2,110
-3,121
Net Income
-1,500
-2,270
1,785
-3,350
Net Change In Cash
1,696
1,386
3,274
272
Free Cash Flow
-1,507
-59
183
-2,703
Cash
8,039
1,320
1,134
1,460
Basic Shares
48,604
31,111
30,880
26,762

Annual Financials

Values in thousands 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Revenue
$3,453
$1,952
$171
$178
Gross Profit
1,079
456
-70
-97
EBITDA
-11,842
-11,755
-9,912
-9,797
EBIT
-12,089
-11,955
-10,138
-9,945
Net Income
-12,318
-11,859
-9,999
-9,948
Net Change In Cash
3,453
1,952
171
178
Free Cash Flow
-11,132
-13,270
-7,794
-8,669
Cash
1,460
5,322
8,160
6,901
Basic Shares
26,762
18,121
15,998
10,696

Earnings Calls

Quarter EPS
2025-09-30
$0
2025-06-30
-$0.03
2025-03-31
-$0.07
2024-12-31
$0.06